In conclusion, our study provides compelling evidence that the expression levels of ACTR3 and other PAMRGs serve as vital prognostic markers in CESC, offering a pathway for enhanced patient stratification and personalized treatment approaches. This evidence concerns the gene ACTR3 and cervical squamous cell carcinoma.